.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
AstraZeneca
Teva
UBS
Queensland Health
Harvard Business School
Boehringer Ingelheim
Fish and Richardson
US Army
Dow

Generated: November 18, 2017

DrugPatentWatch Database Preview

Dexrazoxane hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for dexrazoxane hydrochloride and what is the scope of dexrazoxane hydrochloride freedom to operate?

Dexrazoxane hydrochloride
is the generic ingredient in three branded drugs marketed by Pharmacia And Upjohn, Gland Pharma Ltd, Clinigen Hlthcare, Mylan Institutional, and West-ward Pharms Int, and is included in five NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Dexrazoxane hydrochloride has twenty-two patent family members in sixteen countries.

There are six drug master file entries for dexrazoxane hydrochloride. Seven suppliers are listed for this compound.

Pharmacology for dexrazoxane hydrochloride

Medical Subject Heading (MeSH) Categories for dexrazoxane hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn
ZINECARD
dexrazoxane hydrochloride
INJECTABLE;INJECTION020212-002May 26, 1995APRXYesYes► Subscribe► Subscribe► Subscribe
Mylan Institutional
DEXRAZOXANE HYDROCHLORIDE
dexrazoxane hydrochloride
INJECTABLE;INJECTION200752-002Oct 19, 2011APRXNoNo► Subscribe► Subscribe► Subscribe
Gland Pharma Ltd
DEXRAZOXANE HYDROCHLORIDE
dexrazoxane hydrochloride
INJECTABLE;INJECTION207321-001Nov 28, 2016APRXNoNo► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
DEXRAZOXANE HYDROCHLORIDE
dexrazoxane hydrochloride
INJECTABLE;INJECTION076068-001Sep 28, 2004APRXNoNo► Subscribe► Subscribe► Subscribe
Clinigen Hlthcare
TOTECT
dexrazoxane hydrochloride
INJECTABLE;INJECTION022025-001Sep 6, 2007RXYesYes► Subscribe► Subscribe ► Subscribe
Mylan Institutional
DEXRAZOXANE HYDROCHLORIDE
dexrazoxane hydrochloride
INJECTABLE;INJECTION200752-001Oct 19, 2011APRXNoNo► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
ZINECARD
dexrazoxane hydrochloride
INJECTABLE;INJECTION020212-001May 26, 1995APRXYesYes► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
DEXRAZOXANE HYDROCHLORIDE
dexrazoxane hydrochloride
INJECTABLE;INJECTION076068-002Sep 28, 2004APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: dexrazoxane hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn
ZINECARD
dexrazoxane hydrochloride
INJECTABLE;INJECTION020212-001May 26, 1995► Subscribe► Subscribe
Pharmacia And Upjohn
ZINECARD
dexrazoxane hydrochloride
INJECTABLE;INJECTION020212-002May 26, 1995► Subscribe► Subscribe
Pharmacia And Upjohn
ZINECARD
dexrazoxane hydrochloride
INJECTABLE;INJECTION020212-002May 26, 1995► Subscribe► Subscribe
Pharmacia And Upjohn
ZINECARD
dexrazoxane hydrochloride
INJECTABLE;INJECTION020212-001May 26, 1995► Subscribe► Subscribe
Pharmacia And Upjohn
ZINECARD
dexrazoxane hydrochloride
INJECTABLE;INJECTION020212-001May 26, 1995► Subscribe► Subscribe
Pharmacia And Upjohn
ZINECARD
dexrazoxane hydrochloride
INJECTABLE;INJECTION020212-002May 26, 1995► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: dexrazoxane hydrochloride

Country Document Number Estimated Expiration
Hong Kong1043054► Subscribe
Norway20014433► Subscribe
Spain2220424► Subscribe
Portugal1162981► Subscribe
World Intellectual Property Organization (WIPO)0054782► Subscribe
Australia3272600► Subscribe
Australia769533► Subscribe
China1199644► Subscribe
Germany1162981► Subscribe
Russian Federation2252761► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Merck
Queensland Health
Novartis
Chubb
Moodys
Farmers Insurance
US Department of Justice
UBS
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot